UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
--------------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): April 14, 2003
HUMAN PHEROMONE SCIENCES, INC.
- -------------------------------------------------------------------------------
(Exact name of Registrant as specified in its charter)
CALIFORNIA 0-23544 94-3107202
- -------------------------------------------------------------------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
84 W. SANTA CLARA STREET, SUITE 720, SAN JOSE, CALIFORNIA 95113
- -------------------------------------------------------------------------------
(Address of principal executive offices) (Zip code)
Registrant's telephone number, including area code: (408) 938-3030
--------------------------
- -------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
INFORMATION TO BE INCLUDED IN THE REPORT
ITEM 2. Acquisition or Disposition of Assets
On April 14, 2003, Human Pheromone Sciences, Inc. (the
"Registrant" or "Seller") completed the sale of REALM(R) and innerREALM(R)
trademarks to Niche Marketing Group, Inc. (the "Buyer") pursuant to the Purchase
Agreement by and between the Registrant and Buyer dated as of April 14, 2003. In
the transaction, the Registrant received $1,886,000, of which $420,000 was
previously paid to the Registrant by the Buyer, and of the remaining balance,
$1,280,000 paid upon the signing of the Purchase Agreement and $186,000 to be
paid in monthly payments of $31,000 over a six-month period, commencing on the
first day of the first month after the execution of the Purchase Agreement.
ITEM 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(a) Not Applicable.
(b) Pro Forma Financial Information
Pro forma financial statements for the year ended December 31,
2002 are attached as Exhibit 99.1
(c) Exhibits
2.1* Purchase Agreement by and between among the
Registrant and Buyer dated as of April 14, 2003.
99.1 Pro forma financial statements for the year ended
December 31, 2002.
99.2 Press Release dated April 28, 2003.
*Portions of this exhibit have been omitted pursuant to a
request for confidential treatment.
-2-
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
HUMAN PHEROMONE SCIENCES, INC.
Date: April 28, 2003 By: /s/ William P. Horgan
---------------------------------------------
William P. Horgan, Chief Executive Officer
-3-
EXHIBIT INDEX
2.1* Purchase Agreement by and between among the
Registrant and Buyer dated as of April 14, 2003.
99.1 Pro forma financial statements for the year ended
December 31, 2002.
99.2 Press Release dated April 28, 2003.
*Portions of this exhibit have been omitted pursuant to a request for
confidential treatment.
-4-